The Pharmaceutical Society of Nigeria (PSN) has referred to as on Oyo State Governor Seyi Makinde to sign the Oyo State Drug and Health Commodity Management Agency Bill into regulation, saying the delay has contributed to the excessive value of medicines and different well being commodities within the state.
The society stated the governor’s failure to assent to the bill additionally contributed to poor planning and weak monitoring of medicine throughout the state.
PSN’s Oyo State Chairman, Col. Victor Segun Ajanaku (rtd), made this identified in a press release made obtainable to journalists in Ibadan on Tuesday.
Ajanaku stated the delay had left the state’s well being commodity system with fragmented and parallel provide chains that don’t provide worth for cash. He added that it had additionally resulted in disjointed information methods that restricted efficient planning and decision-making, in addition to weak accountability and monitoring frameworks.
According to him, the costs of commodities at service supply factors remained excessive and inconsistent.
He stated that when the governor signed the bill into regulation, the agency it could set up would supply the state with a sustainable income by way of an environment friendly drug revolving fund system.
He added that the agency would additionally promote accountability, transparency and coordination within the procurement and distribution of well being commodities.
Explaining the aim of the proposed agency, the assertion reads: “The Oyo State Drug and Health Commodity Management Agency is a proposed State Government agency supposed to enhance the procurement, administration, distribution and availability of potent and real medicines and different well being commodities throughout Oyo State. The agency will function a worldwide drive and a part of circumstances that entice each home and worldwide helps for high quality well being commodity safety to the residents.
“The agency can be positioned to function a dependable supply of quality-assured medicines and well being commodities, with procurement targeted on sourcing immediately from producers and different appropriately prequalified suppliers. This is to strengthen product authenticity, high quality, provide reliability and accountability.
“The agency may also operates on the precept of pooled procurement, to guarantee equal entry to low cost, secure and efficient medicines by the general public. The Bill has been handed to regulation by the Oyo State House of Assembly on Thursday sixth February 2025 however is but to obtain assent.
“Despite notable progress, the system continues to face important gaps: Fragmented and parallel provide chains that don’t show worth for cash. Disjointed information methods, limiting efficient planning and decision-making. Weak accountability and monitoring frameworks. High and inconsistent pricing of commodities at service supply factors. Absence of a centralized and retrievable consumption database. Inadequate storage infrastructure and suboptimal storage circumstances.
“The establishment of the agency will: Serve as a sustainable revenue-generating platform for the State through an efficient Drug Revolving Fund system. Operate as a self-sustaining and cost-recovery mechanism, reducing reliance on inconsistent funding sources. Strengthen accountability, transparency, and coordination in the procurement and distribution of health commodities. Enable a centralized, data-driven system, ensuring accurate forecasting, quantification, and planning. Align Oyo State with global best practices, already adopted by over twenty-six (26) states across Nigeria. Guarantee fair and standardized pricing, through direct procurement from manufacturers at negotiated rates. Provide effective governance and oversight through a structured Board. The State has secured UNICEF/Global Fund’s commitment of 4.9 billion naira to provide a purpose-built, Pharmagrade Warehouse”.
WATCH TOP VIDEOS FROM NIGERIAN TRIBUNE TV
